The biopharmaceutical industry is rapidly evolving, and a major catalyst for this change is the increasing use of single-use technologies (SUTs). These innovative, disposable systems are transforming how biologic drugs and vaccines are produced, making manufacturing more cost-effective, faster, and safer. The global market for single-use technologies is experiencing tremendous growth, driven by the demand for better and more efficient production processes. Here’s a closer look at why SUTs are taking the biopharma world by storm.
Single-use technologies refer to disposable systems that are used once and then discarded in the manufacturing process. These systems include components like bioreactors, filtration units, and storage bags, which are vital in the production of biopharmaceutical products. Unlike traditional stainless-steel equipment, which requires cleaning and maintenance between uses, single-use systems help streamline the process by reducing the need for extensive cleaning, saving both time and money.
According to BCC Research the demand for Single-use Technologies for Biopharmaceuticals: Global Markets is grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.